Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Cancer / Oncology News

The FDA Approves Production Process Strategy Of Aplidin(R), New Marine-Derived Anti-Tumor Agent, Proposed By PharmaMar

Main Category: Cancer / Oncology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 24 Oct 2008 - 4:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:2 stars

2 (1 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

The Food and Drug Administration (FDA) has accepted the proposal made by PharmaMar, of the Zeltia Group for the production process of Aplidin®, a new marine-derived anti-tumor agent, in clinical development for the treatment of hematological and solid tumors.

The starting materials for the initiation of the production process have also been approved. Approval from the FDA confirms the strategy PharmaMar has established for the production process of Aplidin®, a process that is already fully defined.

It is an FDA requirement that companies producing drugs submit full paperwork on the synthesis of their medicines. This information on the medicines synthesis together with the approval of the regulatory agency, are included in the registration dossier of a medicine.

About Aplidin®

Aplidin® (Plitidepsin) is a novel anti-tumour agent discovered in the Mediterranean tunicate Aplidium albicans and currently obtained by chemical synthesis. Aplidin® is PharmaMar's second most advanced compound in clinical development. Aplidin® leads to a rapid and persistent induction of apoptosis, inhibits secretion of vascular endothelial growth factor 1 (VEGF1,) and blocks the cell cycle. Aplidin® is being evaluated in preclinical studies and Phase II clinical trials in solid tumours and haematological malignancies, including paediatric tumours in Europe, and the United States. Clinical data have shown antitumour activity in multiple myeloma, renal cancer and aggressive lymphomas. Since late 2005, Aplidin® is undergoing studies in combination with other antitumour agents, as the basis for possible phase III registration studies.

PharmaMar

PharmaMar is the world-leading biopharmaceutical company of the Zeltia Group, and is committed to advancing the treatment of cancer through the discovery and development of new marine-derived medicines. PharmaMar has four novel compounds in clinical development. Yondelis® has received Authorization for Commercialization from the European Commission for treating advanced soft tissue sarcoma. Yondelis® is currently being marketed in the European Union for the treatment of soft tissue sarcomas in adults after failure of standard therapy. Aplidin®, Zalypsis®, and Irvalec® are other marine-derived new agents in clinical development by PharmaMar, which also has a rich pipeline of preclinical candidates, and a strong R&D program.

PharmaMar


Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Forum Icon

Cancer Forum

Discuss issues relating to cancer / oncology in our new forum.

Visit the cancer forum


These are the most read articles from this news category for the last 6 months:
Top Article Star
Long-Held Theory About Biological Clocks Overturned By U-M Discovery
09 Oct 2009
University of Michigan mathematicians and their British colleagues say they have identified the signal that the brain sends to the rest of the body to control biological rhythms, a finding that overturns a long-held theory about our internal clock...


Stages of Breast Cancer image Stages of Breast Cancer

Breast cancer stages tell us the characteristics of the cancer and if it has spread beyond the breast tissue. Doctors can use this information to guide treatment decisions. Learn how staging is vital in determining next steps...

Living with Breast Cancer image Living with Breast Cancer

There are many options for treating breast cancer, including surgery, hormonal treatments, radiation and chemotherapy. All of these treatments have potential physical and emotional side effects. Discover how two women went through treatment and what they did to cope...

View more videos...